Novel prodrugs of amino ceramide-like compounds are provided which inhibit glucosyl ceramide (GlcCer) formation by inhibiting the enzyme GlcCer synthase, thereby lowering the level of glycosphingolipids. The compounds of the present invention have improved GlcCer synthase inhibition activity and are therefore highly useful in therapeutic methods for treating various conditions and diseases associated with altered glycosphingolipid levels.

 
Web www.patentalert.com

< Wortmannin analogs and methods of using same

> Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye

~ 00414